SMSNA For practitioners Updated March 20, 2026

Peyronie's Disease Questionnaire (PDQ)

Evaluates symptoms & psychological effects in patients with PD who have had vaginal intercourse within the last 3 months

Add to Library

Psychological and Physical Symptoms

The questions below ask about the severity of any problems during intercourse within the last 3 months.

 

0%

Reference

Summary

The PD Questionnaire (PDQ) is a self-administered and standardized questionnaire with 15-items created for the intralesional collagenase trials (IMPRESS I and II). It has proven to be highly responsive to symptom changes in men with PD, making it a valuable and effective tool for clinical practice and research. PDQ evaluates symptoms and psychological effects in patients with PD who have had vaginal intercourse within the last 3 months, considering the most recent sexual experience when completing the questionnaire.

 

Scoring

The results section includes a total PDQ score and scores for 3 domains (Psychological/Physical Symptoms, Penile Domain Score & Symptoms Bother Domain Score). Additionally, 2 unscored yes/no questions (Q12 & Q14) will trigger a result if answered "yes."

 

  • Total PDQ Score

    • Sum of all the points in the assessment (70 points possible)

  • Psychological/Physical Symptoms Domain Score

    • Sum of all points for Q1-Q6 (24 points possible)

  • Penile Pain Domain Score

    • Sum of all points for Q7-Q9 (30 points possible)

  • Symptom Bother Domain Score

    • Sum of all points Q10-Q15 (16 points possible)

  • Yes Response (Q12): Difficult or impossible intercourse

    • Appears only if a "yes" response

  • Yes Response (Q14): Intercourse less often

    • Appears only if a "yes" response

 

Considerations

  • A higher score means a more significant negative impact.

  • Q12 & Q14 yes/no choices are not scored. If these questions are "yes", a result will appear below indicating a "yes".

This material was delivered to SMSNA under license from Keenova Therapeutics plc. No reproduction or dissemination of the material for commercial gain is permitted without the consent of Keenova Therapeutics plc, or one of its affiliates.

Instructions

Citation

This material was delivered to SMSNA under license from Keenova Therapeutics plc. No reproduction or dissemination of the material for commercial gain is permitted without the consent of Keenova Therapeutics plc, or one of its affiliates.

 

Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire. J Urol. 2013 Aug;190(2):627-34. doi: 10.1016/j.juro.2013.01.090. Epub 2013 Jan 31. PMID: 23376705.